Kylo Peptides Partners with Freedom Diagnostics for Independent Peptide Verification

Sheridan, Wyoming, Oct. 22, 2026 /CourierPR/ -- Kylo Peptides, a research peptide supplier based in Sheridan, Wyoming, has partnered with Freedom Diagnostics Testing to provide independent verification of its products. The partnership ensures that every lot of research peptides sold by Kylo Peptides undergoes rigorous testing by an outside laboratory, enhancing the transparency and reliability of the company's offerings.

Freedom Diagnostics Testing, based in Franklin, Tennessee, specializes in testing research compounds for identity, purity, and net peptide content. According to the release, the company performs these tests on a fee-for-service basis. For Kylo Peptides, this means that every lot of peptides is sent to Freedom Diagnostics for analysis, with the results being posted on Kylo Peptides' public Certificate of Analysis (COA) Library.

The COA Library serves as a comprehensive database where researchers can trace each product back to its test results. Each lot of peptides is assigned a unique lot ID, which appears on the vial and is matched with the corresponding COA. The lot ID follows a standardized format, such as "2608170152 SD-260728-1," making it easy for researchers to identify and verify the specific batch they are working with.

In one example, Freedom Diagnostics received a Retatrutide 10 mg sample from lot SD-260728-1 on August 17, 2026. The report, issued on August 22, 2026, listed 99.87% HPLC-UV purity and confirmed LC-MS identity. The company also reported a range of purity levels for six lots, ranging from 99.62% to 99.94%.

Kylo Peptides emphasizes the importance of independent verification, stating that internal quality control checks can be biased. By partnering with Freedom Diagnostics, the company ensures that its products are subject to unbiased testing, thereby providing researchers with more reliable data. The partnership also includes other analytical methods such as high-performance liquid chromatography with UV detection (HPLC-UV) for purity testing, liquid chromatography mass spectrometry (LC-MS) for identity testing, inductively coupled plasma mass spectrometry (ICP-MS) for elemental contaminant testing, and limulus amoebocyte lysate (LAL) endotoxin testing.

Kylo Peptides' commitment to quality control extends beyond the partnership with Freedom Diagnostics. The company also works with other laboratories, including Janoshik Analytical, Vanguard Laboratory, and Optiq Health Labs, to ensure a comprehensive testing program. Each certificate of analysis (COA) issued by these laboratories is linked to the corresponding lot ID, providing researchers with detailed and traceable documentation.

This approach ensures that researchers have access to accurate and transparent information, enhancing the credibility of their research.

Kylo Peptides operates under the principle that its products are synthesized and lyophilized in the United States. The company's facilities are registered in Sheridan, Wyoming, and it offers fast dispatch times, with orders typically dispatched within 24 hours on business days. The company's catalog includes more than 100 research compounds and blends, making it a comprehensive supplier for laboratory research.

In summary, Kylo Peptides' partnership with Freedom Diagnostics Testing represents a significant step towards enhancing the transparency and reliability of its research peptide products. By providing independent verification, the company ensures that its customers have access to accurate and trustworthy data, thereby supporting the integrity of their research endeavors.